347850 fundamentals
D&D PHARMATECH INC. financial statements, including revenue, expenses, and profit
The total revenue of 347850 for the last quarter is 1.41 B KRW, and it's 72.04% lower compared to the previous quarter. The net income of Q1 25 is -9.85 B KRW.
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: KRW
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM